About 200 reports

  • Global respiratory disease testing market by test
  • GLOBAL RESPIRATORY DISEASE TESTING MARKET 2014-2019 ($ BILLIONS)
  • Respiratory Disease
  • World
  • Alere Inc.
  • CareFusion Corporation
  • Nihon Kohden Corporation

Bovine Respiratory Disease Treatment Market Overview ##. ##.

  • Cattle
  • Chronic Disease
  • Respiratory Disease
  • World
  • Market Size

Growing prevalence of respiratory diseases such as COPD, asthma is increasing the demand for respiratory disease testing/ diagnostic in North American countries.

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • Forecast

Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) FIG. ## Canada Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) FIG. ## U. K.

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • World
  • Market Size
  • RISE IN HOSPITAL ADMISSION FOR RESPIRATORY DISEASES
  • GROWING INCIDENCE OF CHRONIC RESPIRATORY DISEASES
  • Respiratory Disease
  • World
  • Market Size
  • CareFusion Corporation
  • Teleflex Incorporated
  • RISE IN PREVALENCE OF RESPIRATORY DISEASES
  • INCREASING AWARENESS ABOUT RESPIRATORY DISEASES
  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • RECORDATI ACQUIRED ITALCHIMICI S.P.A.
  • VECTURA MERGED WITH SKYEPHARMA
  • Respiratory Disease
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • SHARE OF DISABILITY ADJUSTED LIFE YEARS FROM CHRONIC RESPIRATORY DISEASE, 2010
  • SHARE OF DEATHS FROM CHRONIC RESPIRATORY DISEASE, 2010
  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group
  • Market drivers

The death rates are consistently higher in men than women for respiratory diseases.

  • Respiratory Disease
  • Boston Scientific Corporation
  • Broncus Medical Inc.
  • Medtronic, Inc.
  • Olympus Corporation
  • YOY REVENUE COMPARISON OF TOP DRUGS FOR ALLERGIC RHINITIS 2012-2014 ($ BILLIONS)
  • Growing a diversified business Simplifying the operating model for increasing efficiency
  • Allergy Drug
  • Respiratory Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Rising incidence of chronic respiratory diseases
  • MARKET DRIVERS
  • Hospital
  • Respiratory Disease
  • United States
  • World
  • Forecast
  • NASAL CANNULA MARKET IN AMERICAS
  • NASAL CANNULA MARKET IN APAC

It can cause various diseases, such as respiratory diseases and cancers, which may require surgical treatment to avoid mortality.

  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • Teleflex Incorporated
  • INHALERS MARKET IN GLOBAL ASTHMA DRUG-DELIVERY DEVICES MARKET 2015-2020 ($ MILLIONS)
  • GLOBAL ASTHMA THERAPEUTICS MARKET: KEY PARAMETERS DRIVING THE MARKET GROWTH 2015
  • Asthma
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Availability of nebulizer substitutes
  • MARKET CHALLENGES
  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • Koninklijke Philips N.V.

Introduction to Asthma and COPD Therapies ##. ## The Pharmaceutical Industry: A Very Brief Overview ##. ## Classifying Respiratory Diseases: Obstructive and Restrictive ##. ##. ## Classifying Respiratory Diseases: Obstructive and Restrictive ##. ## What is Asthma?

  • Asthma
  • Respiratory Disease
  • Therapy
  • World
  • Market Size
  • GLOBAL P.M 2.5 AIR POLLUTION, MEAN ANNUAL EXPOSURE, BY SELECT COUNTRIES, 2015
  • BRAZIL OXYGEN THERAPY EQUIPMENT MARKET, BY APPLICATION

GROWING PREVALENCE OF CHRONIC RESPIRATORY DISEASES IN INDIA.

  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIAL SIZE BY STAGE OF
  • 4.4.3.3 Molecular Target
  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • VENTURI MASKS MARKET IN APAC
  • Venturi masks market in APAC is expected to grow at a CAGR of 17.06% during the forecast period.

The rising older population is linked to the increasing patient pool with low mobility and need for long-term care for Alzheimer' s disease and other chronic respiratory diseases.

  • Respiratory Disease
  • Europe
  • United States
  • World
  • Forecast

Discovers drugs to treat chronic respiratory diseases, including asthma and allergic rhinitis.

  • Respiratory Disease
  • Market Size
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA
  • OTHER PROMINENT VENDORS

It undertakes the discovery and development of drugs for the treatment of respiratory diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • 6.1 Savara Inc.
  • 6.1.1 Business Overview

Cystic fibrosis (CF) is a genetic disease that causes the accumulation of sticky mucus in the lungs, persistent lung infections and persistent and progressive respiratory failure.

  • Respiratory Disease
  • Therapy
  • World
  • Market Size
  • Mast Therapeutics, Inc.
  • 3.3.1 DRIVERS AND OPPORTUNITIES
  • 3.3 FACTORS INFLUENCING MARKET
  • Respiratory Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • ResMed Inc.
  • Strengths
  • 5.1 DISEASE BACKGROUND

CHRONIC RESPIRATORY DISEASES.

  • Respiratory Disease
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.

Key products Dymista OTHER PROMINENT VENDORS Company ADAMIS PHARMACEUTICALS Description Develops and distributes specialty pharmaceutical products in therapeutic areas including oncology, immunology, infectious diseases, allergy, and respiratory Develops drugs to treat and prevent

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • 9.1 REFERENCES
  • 5.3 FIRST-IN-CLASS PIPELINE PROGRAMS TARGETING NOVEL MOLECULAR TARGETS

Major Respiratory Diseases.

  • Respiratory Disease
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG
  • Strength
  • Vendor landscape

The company is a global biopharmaceutical company that manufactures, develops, distributes, and researches medicines for the treatment of cardiovascular and metabolic diseases; oncology diseases; respiratory diseases, inflammation and autoimmunity disorders and in

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Asthma Therapeutics, Global, Clinical Trial Size per Individual Trial by Stage of
  • 6.6.1 TREATMENT USAGE PATTERNS

Pediatric Allergy and Respiratory Disease.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • ADULT POPULATION WITH SINUSITIS AND CHRONIC RHINITIS IN US 2014 (MILLION)

Respiratory diseases such as sinusitis and hay fever/ rhinitis are some of the diseases that affect a large population and are therefore a major concern.

  • Allergy Drug
  • Respiratory Disease
  • Forecast
  • Novartis AG
  • Sanofi S.A.

Introduction to Asthma and COPD Therapies ##. ## The Pharmaceutical Industry: A Very Brief Overview ##. ## Classifying Respiratory Diseases: Obstructive and Restrictive ##. ##. ## Classifying Respiratory Diseases: Obstructive and Restrictive ##. ## What is Asthma?

  • Asthma
  • Respiratory Disease
  • Therapy
  • World
  • Market Size
  • Market drivers
  • Introduction

They are used for the treatment of cystic fibrosis, asthma, COPD, and other respiratory diseases.

  • Respiratory Disease
  • Bespak plc
  • Consort Medical plc
  • Gerresheimer AG
  • Nypro Inc.